Stevioside was able to lower blood glucose in type 2 diabetic subjects [20] and in a non-obese animal model of type 2 diabetes i.e. the Goto Kakizaki rat [21] by both increasing insulin release and suppressing glucagon levels [22]. The gene discussed is GCG; the disease is type 2 diabetes mellitus.